EXOTHERA
LIVE

Serial Number

79296890

Owner

EXOTHERA, société anonyme

Attorney

Andrew D. Dorisio

Filing Date

Sep 18, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EXOTHERA Trademark

Serial Number: 79296890 • Registration: 6458341

EXOTHERA is a trademark filed by EXOTHERA, société anonyme on September 18, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EXOTHERA, société anonyme (3 trademarks)

Zoning de Jumet,

Entity Type: 99

Trademark Details

Filing Date

September 18, 2020

Registration Date

August 24, 2021

Published for Opposition

June 8, 2021

Goods & Services

Custom manufacturing of biologics, namely, manufacturing of biologics using biological organisms in the manufacturing process; custom manufacturing of pharmaceuticals, antibiotic medicines and materials for clinical trials and for commercial supply by pharmaceutical compounders; bio manufacturing for others, namely, custom manufacturing of pharmaceuticals and materials for clinical trials for commercial supply, using biological organisms in the manufacturing process; custom manufacturing services in the field of biologics, pharmaceuticals, biopharmaceuticals, health care, cell culture and gene therapy and medical products; custom manufacturing of medications and parts of medications on the base of specific compositions or active constituents for others to support clinical trials and commercial supply; treatment of pharmaceutical and chemical products and their components during the custom manufacture of pharmaceuticals and biopharmaceuticals; providing advice related to the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply; providing information in the field of the custom manufacture of pharmaceuticals and materials for clinical trials and for commercial supply

Scientific research and development applied in particular in the biological, technological and biotechnological fields, in the medical, biomedical, chemical, pharmaceutical and veterinary fields, in the fields of immunology, epidemiology, vaccinology and therapies and in the field of gene and cellular therapy; scientific and technological research and development for the pharmaceutical and biotechnology industries; quality control services on pharmaceutical products for others; scientific research and technological development and advice services, namely, analytical testing, biosafety testing, reporting and laboratory services for others, custom design and development of chemical reagents and biochemical assays, formulation and process development for the manufacturing of medicinal products; engineering services; scientific and technological consultancy on process development relating to manufacture of biologics; industrial process development for manufacturing of medical preparations; engineering services and scientific and technological consultancy, all on production units for the development of biologics; design of tools for the production of biologics; advisory services relating to industrial engineering in the field of manufacturing of biologics; biochemical engineering services; technical engineering services in the field of manufacturing of biologics; rental of laboratory apparatus and instruments; technological development services, technology advice and information services and engineering consultation services in the field of the production of biologics; scientific research services in the medical sector, namely, conducting clinical trials for others; providing scientific research information in the medical sector, in the field of clinical trials; scientific laboratory services related to the culture of stem cells or differentiated cells and biological materials to be used in cellular therapies and in clinical trials and for the manufacturing of commercial products

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 3, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 28, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 4, 2022 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 24, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 24, 2021 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 29, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 29, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 29, 2021 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 8, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 8, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 19, 2021 NONP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 9, 2021 ADCH
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2021 TROA
REFUSAL PROCESSED BY IB
Mar 22, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 26, 2021 RFCS
REFUSAL PROCESSED BY MPU
Feb 26, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 6, 2021 RFCR
NON-FINAL ACTION WRITTEN
Feb 5, 2021 CNRT
ASSIGNED TO EXAMINER
Feb 3, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 6, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 29, 2020 REPR